what are the Recommendations for Treatment of Cardiac Amyloidosis
Referenced studies that support the recommendations are summa-
rized in the Online Data Supplements.?
In patients with cardiac amyloidosis and AF, anticoagulation is reasonable to reduce the risk of stroke regardless of the CHADS-VASc 2 2 (congestive heart failure, hypertension, age ?75 years, diabetes mellitus, stroke or transient ischemic attack [TIA], vascular disease, age 65 to 74 years, sex category) score.